Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Research article

Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi

Authors: Ralf Weigel, Mindy Hochgesang, Martin WG Brinkhof, Mina C Hosseinipour, Matt Boxshall, Eustice Mhango, Brains Nkwazi, Hannock Tweya, Maggie Kamlaka, Frederick Chagwera, Sam Phiri

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

Loss to follow-up is a major challenge of antiretroviral treatment (ART) programs in sub-Saharan Africa. Our objective was to a) determine true outcomes of patients lost to follow-up (LTFU) and b) identify risk factors associated with successful tracing and deaths of patients LTFU from ART in a large public sector clinic in Lilongwe, Malawi.

Methods

Patients who were more than 2 weeks late according to their last ART supply and who provided a phone number or address in Lilongwe were eligible for tracing. Their outcomes were updated and risk factors for successful tracing and death were examined.

Results

Of 1800 patients LTFU with consent for tracing, 724 (40%) were eligible and tracing was successful in 534 (74%): 285 (53%) were found to be alive and on ART; 32 (6%) had stopped ART; and 217 (41%) had died. Having a phone contact doubled tracing success (adjusted odds ratio, aOR = 2.1, 95% CI 1.4-3.0) and odds of identifying deaths [aOR = 1.8 (1.2-2.7)] in patients successfully traced. Mortality was higher when ART was fee-based at initiation (aOR = 2.3, 95% CI 1.1-4.7) and declined with follow-up time on ART. Limiting the analysis to patients living in Lilongwe did not change the main findings.

Conclusion

Ascertainment of contact information is a prerequisite for tracing, which can reveal outcomes of a large proportion of patients LTFU. Having a phone contact number is critical for successful tracing, but further research should focus on understanding whether phone tracing is associated with any differential reporting of mortality or LTFU.
Appendix
Available only for authorised users
Literature
1.
go back to reference Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O, Salaniponi FM: Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet. 2001, 358: 410-414. 10.1016/S0140-6736(01)05551-9.CrossRefPubMed Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O, Salaniponi FM: Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet. 2001, 358: 410-414. 10.1016/S0140-6736(01)05551-9.CrossRefPubMed
2.
go back to reference Rosen S, Fox MP, Gill CJ: Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007, 4: e298-10.1371/journal.pmed.0040298.CrossRefPubMedPubMedCentral Rosen S, Fox MP, Gill CJ: Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007, 4: e298-10.1371/journal.pmed.0040298.CrossRefPubMedPubMedCentral
3.
go back to reference Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, et al: Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008, 86: 559-567. 10.2471/BLT.07.044248.CrossRefPubMedPubMedCentral Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, et al: Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008, 86: 559-567. 10.2471/BLT.07.044248.CrossRefPubMedPubMedCentral
4.
go back to reference Brinkhof MW, Pujades-Rodriguez M, Egger M: Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE. 2009, 4: e5790-10.1371/journal.pone.0005790.CrossRefPubMedPubMedCentral Brinkhof MW, Pujades-Rodriguez M, Egger M: Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE. 2009, 4: e5790-10.1371/journal.pone.0005790.CrossRefPubMedPubMedCentral
5.
go back to reference Yu JK, Tok TS, Tsai JJ, Chang WS, Dzimadzi RK, Yen PH, et al: What happens to patients on antiretroviral therapy who transfer out to another facility?. PLoS ONE. 2008, 3: e2065-10.1371/journal.pone.0002065.CrossRefPubMed Yu JK, Tok TS, Tsai JJ, Chang WS, Dzimadzi RK, Yen PH, et al: What happens to patients on antiretroviral therapy who transfer out to another facility?. PLoS ONE. 2008, 3: e2065-10.1371/journal.pone.0002065.CrossRefPubMed
6.
go back to reference National AIDS Commission: HIV and Syphilis Sero- Survey and National HIV prevalence and AIDS Estimates Report 2007. 2007, Ministry of Health and Population, The Republic of Malawi. National AIDS Commission: HIV and Syphilis Sero- Survey and National HIV prevalence and AIDS Estimates Report 2007. 2007, Ministry of Health and Population, The Republic of Malawi.
7.
go back to reference Harries AD, Libamba E, Schouten EJ, Mwansambo A, Salaniponi FM, Mpazanje R: Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis. BMJ. 2004, 329: 1163-1166. 10.1136/bmj.329.7475.1163.CrossRefPubMedPubMedCentral Harries AD, Libamba E, Schouten EJ, Mwansambo A, Salaniponi FM, Mpazanje R: Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis. BMJ. 2004, 329: 1163-1166. 10.1136/bmj.329.7475.1163.CrossRefPubMedPubMedCentral
8.
go back to reference Libamba E, Makombe SD, Harries AD, Schouten EJ, Yu JK, Pasulani O, et al: Malawi's contribution to "3 by 5": achievements and challenges. Bull World Health Organ. 2007, 85: 156-160. 10.2471/BLT.05.033688.CrossRefPubMedPubMedCentral Libamba E, Makombe SD, Harries AD, Schouten EJ, Yu JK, Pasulani O, et al: Malawi's contribution to "3 by 5": achievements and challenges. Bull World Health Organ. 2007, 85: 156-160. 10.2471/BLT.05.033688.CrossRefPubMedPubMedCentral
9.
go back to reference Lowrance D, Filler S, Makombe S, Harries A, Aberle-Grasse J, Hochgesang M, et al: Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi. Trop Med Int Health. 2007, 12: 377-381. 10.1111/j.1365-3156.2006.01800.x.CrossRefPubMed Lowrance D, Filler S, Makombe S, Harries A, Aberle-Grasse J, Hochgesang M, et al: Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi. Trop Med Int Health. 2007, 12: 377-381. 10.1111/j.1365-3156.2006.01800.x.CrossRefPubMed
10.
go back to reference HIV unit: Treatment of AIDS. Guidelines for the use of antiretroviral therapy in Malawi. 2003, Ministry of Health, Malawi, [First Editon, October 2003]. HIV unit: Treatment of AIDS. Guidelines for the use of antiretroviral therapy in Malawi. 2003, Ministry of Health, Malawi, [First Editon, October 2003].
11.
go back to reference HIV unit: Treatment of AIDS. Guidelines for the use of antiretroviral therapy in Malawi. 2006, Ministry of Health, Malawi, [Second Editon, April 2006]. HIV unit: Treatment of AIDS. Guidelines for the use of antiretroviral therapy in Malawi. 2006, Ministry of Health, Malawi, [Second Editon, April 2006].
12.
go back to reference Libamba E, Makombe S, Mhango E, de Ascurra TO, Limbambala E, Schouten EJ, et al: Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi. Bull World Health Organ. 2006, 84: 320-326.PubMedPubMedCentral Libamba E, Makombe S, Mhango E, de Ascurra TO, Limbambala E, Schouten EJ, et al: Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi. Bull World Health Organ. 2006, 84: 320-326.PubMedPubMedCentral
13.
go back to reference HIV unit: ARV therapy in Malawi- Results up to 31st December 2005. 2005, Lilongwe, Malawi, Ministry of Health and Population HIV unit: ARV therapy in Malawi- Results up to 31st December 2005. 2005, Lilongwe, Malawi, Ministry of Health and Population
14.
go back to reference Phiri S, Weigel R, Hosseinipour M, Boxshall M, Neuhann F: The Lighthouse- a centre for comprehensive HIV/AIDS treatment and care in Malawi. A case study. Perspectives and practice in antiretroviral treatment. 2004, Geneva, WHO Phiri S, Weigel R, Hosseinipour M, Boxshall M, Neuhann F: The Lighthouse- a centre for comprehensive HIV/AIDS treatment and care in Malawi. A case study. Perspectives and practice in antiretroviral treatment. 2004, Geneva, WHO
15.
go back to reference Hosseinipour MC, Neuhann FH, Kanyama CC, Namarika DC, Weigel R, Miller W, et al: Lessons learned from a paying antiretroviral therapy service in the public health sector at kamuzu central hospital, Malawi: 1-year experience. J Int Assoc Physicians AIDS Care (Chic Ill). 2006, 5: 103-108. 10.1177/1545109706288722.CrossRef Hosseinipour MC, Neuhann FH, Kanyama CC, Namarika DC, Weigel R, Miller W, et al: Lessons learned from a paying antiretroviral therapy service in the public health sector at kamuzu central hospital, Malawi: 1-year experience. J Int Assoc Physicians AIDS Care (Chic Ill). 2006, 5: 103-108. 10.1177/1545109706288722.CrossRef
17.
go back to reference Tweya H, Gareta D, Chagwera F, Ben-Smith A, Mwenyemasi J, Chiputula F, et al: Early active follow-up of patients on antiretroviral therapy (ART) who are lost to follow-up: the 'Back-to-Care' project in Lilongwe, Malawi. Trop Med Int Health. 2010, 15 (Suppl 1): 82-89. 10.1111/j.1365-3156.2010.02509.x.CrossRefPubMed Tweya H, Gareta D, Chagwera F, Ben-Smith A, Mwenyemasi J, Chiputula F, et al: Early active follow-up of patients on antiretroviral therapy (ART) who are lost to follow-up: the 'Back-to-Care' project in Lilongwe, Malawi. Trop Med Int Health. 2010, 15 (Suppl 1): 82-89. 10.1111/j.1365-3156.2010.02509.x.CrossRefPubMed
18.
go back to reference Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, Yiannoutsos CT, et al: Understanding Reasons for and Outcomes of Patients Lost to Follow-Up in Antiretroviral Therapy Programs in Africa Through a Sampling-Based Approach. J Acquir Immune Defic Syndr. 2009, 53: 405-411.CrossRef Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, Yiannoutsos CT, et al: Understanding Reasons for and Outcomes of Patients Lost to Follow-Up in Antiretroviral Therapy Programs in Africa Through a Sampling-Based Approach. J Acquir Immune Defic Syndr. 2009, 53: 405-411.CrossRef
19.
go back to reference Krebs DW, Chi BH, Mulenga Y, Morris M, Cantrell RA, Mulenga L, et al: Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care. 2008, 20: 311-317. 10.1080/09540120701594776.CrossRefPubMed Krebs DW, Chi BH, Mulenga Y, Morris M, Cantrell RA, Mulenga L, et al: Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care. 2008, 20: 311-317. 10.1080/09540120701594776.CrossRefPubMed
20.
go back to reference Hochgesang M, Kuyenda A, Hosseinipour M, Phiri S, Weigel R, Mhango E, et al: Active Tracing of ART patients lost to follow up at Lighthouse shows that few 'stopped' treatment for their own reason, but many have died. 2006, XVI International AIDS conference, Toronto, Canada, Abstract TUPE0119. Hochgesang M, Kuyenda A, Hosseinipour M, Phiri S, Weigel R, Mhango E, et al: Active Tracing of ART patients lost to follow up at Lighthouse shows that few 'stopped' treatment for their own reason, but many have died. 2006, XVI International AIDS conference, Toronto, Canada, Abstract TUPE0119.
21.
go back to reference Boulle A, van CG, Hilderbrand K, Cragg C, Abrahams M, Mathee S, et al: Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS. 2010, 24: 563-572. 10.1097/QAD.0b013e328333bfb7.CrossRefPubMed Boulle A, van CG, Hilderbrand K, Cragg C, Abrahams M, Mathee S, et al: Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS. 2010, 24: 563-572. 10.1097/QAD.0b013e328333bfb7.CrossRefPubMed
22.
go back to reference Fox MP, Brennan A, Maskew M, Macphail P, Sanne I: Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa. Trop Med Int Health. 2010, 15: 405-413. 10.1111/j.1365-3156.2010.02508.x.CrossRefPubMedPubMedCentral Fox MP, Brennan A, Maskew M, Macphail P, Sanne I: Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa. Trop Med Int Health. 2010, 15: 405-413. 10.1111/j.1365-3156.2010.02508.x.CrossRefPubMedPubMedCentral
23.
go back to reference Maskew M, Macphail P, Menezes C, Rubel D: Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy. S Afr Med J. 2007, 97: 853-857.PubMed Maskew M, Macphail P, Menezes C, Rubel D: Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy. S Afr Med J. 2007, 97: 853-857.PubMed
24.
go back to reference Neethling M, Maskew M, Maotoe T, Miller R, Majuba P, Praekelt G, et al: Text message reminders as a strategy to improve appointment attendance at HIV treatment facilities. 2009, 5th IAS Conference on HIV Pathogenesis and Treatment, Cape Town, South Africa, Abstract LBPED02. Neethling M, Maskew M, Maotoe T, Miller R, Majuba P, Praekelt G, et al: Text message reminders as a strategy to improve appointment attendance at HIV treatment facilities. 2009, 5th IAS Conference on HIV Pathogenesis and Treatment, Cape Town, South Africa, Abstract LBPED02.
Metadata
Title
Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi
Authors
Ralf Weigel
Mindy Hochgesang
Martin WG Brinkhof
Mina C Hosseinipour
Matt Boxshall
Eustice Mhango
Brains Nkwazi
Hannock Tweya
Maggie Kamlaka
Frederick Chagwera
Sam Phiri
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-31

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.